[HTML][HTML] Repurposing of kinase inhibitors for treatment of COVID-19
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of Kinase Inhibitors for Treatment of COVID-19.
E Weisberg, A Parent, PL Yang, M Sattler… - Pharmaceutical …, 2020 - europepmc.org
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of Kinase Inhibitors for Treatment of COVID-19.
E Weisberg, A Parent, PL Yang… - Pharmaceutical …, 2020 - search.ebscohost.com
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
[PDF][PDF] Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang, M Sattler, Q Liu… - Pharm …, 2020 - researchgate.net
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of kinase inhibitors for treatment of COVID-19.
E Weisberg, A Parent, PL Yang, M Sattler, Q Liu, Q Liu… - 2020 - cabidigitallibrary.org
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang… - Pharmaceutical …, 2020 - search.proquest.com
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
[HTML][HTML] Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang, M Sattler… - Pharmaceutical …, 2020 - ncbi.nlm.nih.gov
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang… - Pharmaceutical …, 2020 - pubmed.ncbi.nlm.nih.gov
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang… - Pharmaceutical …, 2020 - pubmed.ncbi.nlm.nih.gov
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
[PDF][PDF] Repurposing of Kinase Inhibitors for Treatment of COVID-19
E Weisberg, A Parent, PL Yang, M Sattler, Q Liu… - Pharm …, 2020 - researchgate.net
The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …
syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the …